Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, April 13, 2023
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
[ Thu, Apr 13th 2023
] - WOPRAI
Jasper Hellweg Maintained (AZN) at Strong Buy with Increased Target to $85 on, Apr 13th, 2023
Jasper Hellweg of Argus Research, Maintained "AstraZeneca PLC" (AZN) at Strong Buy with Increased Target from $75 to $85 on, Apr 13th, 2023.
Jasper has made no other calls on AZN in the last 4 months.
There is 1 other peer that has a rating on AZN. Out of the 1 peers that are also analyzing AZN, 0 agree with Jasper's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jasper
- Etzer Darout of "BMO Capital" Initiated at Buy and Held Target at $82 on, Thursday, January 5th, 2023
